Evidence map›Paper›PMID 36612322›Full record

ArticleCancers2022

Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.

Jomnarong Lertsuwan, Kornkamon Lertsuwan, Anyaporn Sawasdichai, Nathapol Tasnawijitwong, Ka Ying Lee, Philip Kitchen, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman, Jutamaad Satayavivad

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. The clinical significance for primary tumor surgery in metastatic head and neck adenoid cystic carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jomnarong LertsuwanLaboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand.ORCID 0000-0002-5701-2382
Kornkamon LertsuwanDepartment of Biochemistry, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand.ORCID 0000-0001-7852-1920
Anyaporn SawasdichaiLaboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand.
Nathapol TasnawijitwongLaboratory of Pharmacology, Chulabhorn Research Institute, Bangkok 10210, Thailand.
Ka Ying LeeInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Philip KitchenInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0002-1558-4673
Simon AffordInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
Kevin GastonDivision of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-7349-5513
Padma-Sheela JayaramanInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Jutamaad SatayavivadLaboratory of Pharmacology, Chulabhorn Research Institute, Bangkok 10210, Thailand.ORCID 0000-0003-3642-262X
Chulabhorn Research Institute · THUniversity of Birmingham · GBMahidol University · THUniversity of Nottingham · GB

Funding

Medical Research Council MR/N012615/1
6 · The paper itself

Abstract

Authors would like to make a correction to the previous article [...].

Identifiers

PMID36612322
PMCPMC9817831
OpenAlexW4313247072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.